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bstract Objective: To evaluate the hypolipemic and antioxidant effects of soy and green tea alone and/or
in association in dyslipidemic subjects.
Methods: One hundred dyslipidemic individuals were allocated into four groups. The soy group
ingested 50 g of soy (kinako) daily, and the green tea group ingested 3 g of green tea in 500 mL of
water per day. A third group ingested 50 g of soy and 3 g of green tea daily, and the control group
had a hypocholesterolemic diet. Evaluations were performed at baseline and after 45 and 90 d.
Plasma levels of total cholesterol, high-density lipoprotein, and triacylglycerols were evaluated by
automated methods. Low-density lipoprotein (LDL) cholesterol was calculated using the Friedewald
equation. LDL was isolated by ultracentrifugation. Total plasma antioxidant capacity and plasma levels
of total lipid hydroperoxides and those linked to LDL were evaluated by chemiluminescence. The results
were expressed as median values and their 25th to 75th percentiles, with a 5% level of significance.
Results: No significant difference occurred in LDL, high-density lipoprotein cholesterol, and triacyl-
glycerol levels across groups. However, a statistically significant difference in total cholesterol occurred
within the soy/green tea group 45 and 90 d after intervention. No statistically significant difference
occurred in plasma levels of lipid hydroperoxides or those linked to LDL in any of the groups studied.
All the groups that used soy and/or green tea presented increased total plasma antioxidant potential.
Conclusion: Soy and green tea, alone or in combination, increased the total antioxidant potential
of hypercholesterolemic patients, whereas only the combination decreased total cholesterol
levels. © 2008 Elsevier Inc. All rights reserved.
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563M. Bertipaglia de Santana et al. / Nutrition 24 (2008) 562–568Introduction
In the past 10 y, numerous researchers and the food
ndustry have demonstrated growing interest in polyphe-
ols. The main reason is the recognition of their antioxidant
roperties, their great abundance in nature, and their prob-
ble role in the prevention of several pathologies associated
ith oxidative stress, such as cancer and cardiovascular and
eurodegenerative disorders. The beneficial effects of these
ubstances depend on the quantity consumed and their bio-
vailability [1].
Several studies have considered that the hypocholester-
lemic effect of vegetable proteins, in particular soy, is due
o the high fecal excretion of steroids as a consequence of
ntestinal absorption reduction. A large fecal excretion of
teroids could lead to increased biliary acid production from
lasma cholesterol, thus reducing its own levels [2]. More-
ver, soy protein amino acids and isoflavones appear to
xert synergic action on improving lipid metabolism with
he activation of receptors for low-density lipoprotein
LDL) [3].
From the chemical viewpoint, polyphenol compounds
such as isoflavones or flavanoids found in soy, tea, or
ines) are the most promising natural antioxidants with
egard to the inhibition of atherogenic modifications of LDL
4]. Even though the action mechanism of these polyphe-
ols is not fully understood, the hypolipemic and protective
ctions against LDL oxidation are attributed to genistein
nd daidzein, in the case of soy, and to catechins, in the case
f tea [5,6]. Considering the lack of consensus regarding
hese actions in the use of soy and green tea and, to our
nowledge, the lack of studies that have made use of this
ssociation in humans to evaluate the lipid profile and an-
lyze the total plasma antioxidant potential, the present
tudy is justified.
aterials and methods
asuistic
One hundred four hypercholesterolemic patients, 40
ale and 64 female, were selected at a cardiology clinic in
ondrina, Paraná, Brazil. Four patients, one male and three
emale, left during the development of the protocol for
ersonal reasons. Therefore, 100 individuals, 39 male and
1 female, with a mean age of 52.2  12.2 y, participated
n the study.
The patients were sedentary and oriented to make no
hanges in their habitual lifestyle. This was monitored by
eans of a questionnaire that was filled out every time the
atients returned to the clinic for blood collection. Further-
ore, compliance was measured by this questionnaire and
ounting green tea and soy packages when patients returned
or their clinical and nutritional evaluations. Body weight
as measured to the nearest 0.1 kg by using an electronic Lcale, with individuals wearing minimal clothing; height
as measured to the nearest 0.1 cm by using a stadiometer
nd was used to calculate body mass index (BMI; kilograms
er square meter). The baseline BMIs (mean SD) for each
roup (green tea, soy, soy/green tea, and control) were
6.2  3.3, 25.4  3.2, 26.1  3.3, and 27.1  3.3 kg/m2,
espectively. Subjects in each comparison consumed similar
ietary fat.
The inclusion criteria were patients 18 y old, with
otal cholesterol plasma levels 220 mg/dL. Individuals
ho presented with diabetes mellitus, hypothyroidism, or
ther causes of secondary dyslipidemia were excluded
rom the study. Women receiving hormone replacement
herapy and patients who were using hypolipemic medi-
ation, isoflavones, soy, and/or green tea for 40 d before
ntry into the protocol were also excluded. No modification
ccurred in the treatment of patients receiving hypertensive
edication.
All participants were informed regarding the procedures
hey would undergo and signed a term of free informed
onsent. This study and the term were approved by the
thics in human research committee of the Londrina Uni-
ersity Hospital.
tudy design: randomized controlled trial
Patients were randomized to one of four groups (green
ea, soy, soy/green tea, and control) using sealed opaque
nvelopes indicating treatment allocation. Randomiza-
ion envelopes were prepared at study inception and a
andom number sequence was obtained from a table of
andomized numbers. After orientation by a nutritionist,
articipants used the products they were offered for 90 d.
he soy group (n  25) ingested 50 g/d of kinako
toasted ground soy bean, with 31.2 mg of isoflavones)
hroughout their daily meals: breakfast, lunch, and din-
er. The green tea group (n  25) ingested 500 mL of tea
dry leaves 3 g/vol, prepared by brewing for 10 min in
00 mL of water containing 145 mg of epigallocatechin-
-gallate [EGCG]) throughout the day. The soy/green tea
roup (n  25) ingested the same as the soy and green tea
roups. The control group (n  25) received a standard
ypocholesterolemic diet low in saturated fat and choles-
erol contents and high in polyunsaturated fatty acids
PUFAs) [7]. From knowledge of the habitual intake of
ach individual, the control diet consisted of decreased
ed meat intake (beef and pork, a daily habit in Brazil),
ggs, bacon, and replacing milk and butter with skimmed
ilk and margarine.
All groups were evaluated on three occasions by a blind
ssessor: at baseline and after 45 and 90 d. The soy was
rovided by the Brazilian Farming Research Company
EMBRAPA-SOJA, Londrina, Paraná, Brazil) and pro-
essed by the Kinasoy Company of Londrina. The green tea
rand used was Yamamotoyama (Midori Indústria de Chá
tda., São Paulo, Brazil) and donated by the manufacturer.
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564 M. Bertipaglia de Santana et al. / Nutrition 24 (2008) 562–568he batches and procedures of the products used by these
roups were the same.
nalytical procedures
xtraction and separation of isoflavones for
igh-performance liquid chromatography
Separation and quantification of the isoflavones was per-
ormed using a Waters liquid chromatograph (model 2690,
atters & Associates, Milford, MA, USA) with an auto-
atic sample injector [8]. The patients ingested the follow-
ng concentrations of aglycone isoflavones in milligrams-
ercent (m/m) per 100 g of kinako: daidzein 23.2, glycitein
1.2, and genistein 8.0.
etermination of catechin EGCG by high-performance
iquid chromatography in green tea samples
Separation and quantification of EGCG was performed
sing a Waters liquid chromatograph (model 2690) with an
utomatic sample injector [9]. The concentration of EGCG
n 100 g of green tea leaves used by the patients was 4.84 g
m/m). The amount of EGCG present in the green tea
ngested by the patients was 145 mg/500 mL.
lood collection
Approximately 20 mL of blood was collected in vac-
um tubes containing ethylene-diaminetetra-acetic acid
r without a coagulant. Immediately after collection, the
amples were chilled on ice. To obtain the plasma, the
ubes were placed in a Fanem refrigerated centrifuge
Model 280 R, Guarulhos, São Paulo, Brazil) at 4°C and
otated at 3000  g.
DL separation
To obtain the LDL level, the following gradient was
repared: 0.5 mL of saline (density [d]  1.182 g/mL), 3.0
L of plasma (d  1.090 g/mL), 1.0 mL of saline (d 
.056 g/mL), 1.0 mL of saline (d  1.045 g/mL), 1.5 mL of
aline (d  1.034 g/mL), 1.5 mL of saline (d  1.024
/mL), and 1.0 mL of saline (d  1.019 g/mL). The pH of
ll these saline solutions was adjusted to 7.4 [10]. This
radient was centrifuged in a Sorvall ultracentrifuge (model
ro-80, Sorvall, Newtown, CT, USA), at 284 000  g for
4 h at 4°C.
From the top of the tube, aliquots were removed in the
ollowing order: 1.0 mL, the aliquot considered to be very
DL; 6.0 mL, the aliquot considered to be LDL; and 3.5
L, the aliquot considered to be infranatant.
Next, the LDL aliquot was dialyzed in 0.9% NaCl solu-
ion for 12 h to remove the excess KBr.
lasma parameters
Biochemical quantifications were measured in a bio-
hemical autoanalyzer (Dade AR, Newark, NJ, USA) using
ade Behring kits. Total cholesterol was quantified by theholesterol oxidase technique. Whenever possible, LDL iholesterol was calculated by the Friedewald equation [11].
igh-density lipoprotein (HDL) cholesterol was quantified
y the selective precipitation method using a buffered phos-
hotungstate reagent. Triacylglycerols were analyzed by
eans of the bichromatic enzymatic technique, using lipase
nd glycerol dehydrogenase.
otal plasma antioxidant capacity
Total plasma antioxidant capacity (TRAP) was evaluated
y chemiluminescence [12]. This methodology detects hy-
rosoluble antioxidants in the plasma. The 2,2 azobis gen-
rates peroxyl radicals rapidly, through an interaction cen-
ered on carbon and molecular oxygen, causing the
xidation of lipids and proteins in biomolecules [13]. These
ree radicals react with luminol, which acts as a signal
mplifier, producing chemiluminescence. This reaction is
nhibited by superoxide dismutase, catalase, and vitamin E
nalogs. The results were expressed as micromolar Trolox.
his experiment was conducted in a Beckman  counter
model LS 6000, Beckman, Fullerton, CA, USA) in non-
oincident counting mode for 30 min and with a response
ange of 300–620 nm.
ipid hydroperoxides
Evaluation of the formation of lipid hydroperoxides was
lso realized by chemiluminescence [14]. The reaction me-
ium was placed in 20-mL plastic flasks for scintillation.
he medium consisted of 1750 L of 30 mM phosphate
uffer, pH 7.4, and 20 mM (v/v) KCl added to 250 L of
lasma or LDL and 20 L of tert-butylhydroperoxide at a
nal concentration of 3 mM in 2.0 mL of reaction medium.
Chemiluminescence was measured in a Beckman 
ounter (model LS 6000) in non-coincident counting mode
or 30 min and with a response range of 300–620 nm. The
cintillation flasks were maintained in darkness and the
eaction was realized in a dark environment to avoid phos-
horescence of the flasks. This experiment was conducted at
temperature of 30°C and the results were expressed in
ounts per minute.
tatistical analysis
Initially, a descriptive analysis of the data was per-
ormed. Because the variables did not confirm to the as-
umptions of normality (lipid and antioxidant profiles), the
ata were presented as median and 25th to 75th quartiles.
he percentage of change of outcome measurements was
erformed between baseline and final assessment (90 d). To
ompare the variables and percentage of change among and
ithin groups, at three moments in time, analysis of vari-
nce for repeated measures was used. Mauchly’s sphericity
est was applied, and when it was violated, technical cor-
ections were performed using the Greenhouse-Geisser test.
hen the F test was significant, complementary analysis
as performed using Bonferroni’s test for multiple compar-sons. A statistical significance of 5% was adopted (P 
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565M. Bertipaglia de Santana et al. / Nutrition 24 (2008) 562–568.05). All analyses were performed with the intention to
reat. SPSS 11.5 for Windows (SPSS, Inc., Chicago, IL,
SA) was used for data analysis.
esults
Mean ages were 51.3  13.4 y in the green tea group (9
en and 16 women), 52.7  10.8 y in the soy group (11
en and 14 women), 57.0  11.2 y in the soy/green tea
roup (8 men and 17 women), and 48.0  12.4 y in the
ontrol group (11 men and 14 women).
The TRAP presented statistically significant differences
ithin all groups and between the green tea and control
roups. After the 90-d intervention, the tea group presented
significant difference compared with the control group and
ith percentage of change (17% of improvement in the
reen tea group versus 30.9% of worsening in the control
roup, P  0.0001). After 45 and 90 d of treatment with
reen tea, there was a significant difference (P  0.007)
rom baseline values. In relation to the soy group, signifi-
ance was found when comparing baseline and 45-d inter-
entions (P  0.001) with 19% of change. In the soy/green
ea group, significant differences were found between the
aseline evaluation and the 45-d intervention (P  0.006)
nd between the baseline evaluation and the 90-d interven-
ion (P 0.007) with 14% of change. With the exception of
he control group, at the end of intervention, all groups
resented an increase in antioxidant defenses. Statistically
ignificant increases in TRAP occurred for the soy, green
ea, and soy/green tea groups and a significant decrease in
he control group (Table 1).
Regarding the pro-oxidant profile, no statistically signif-
cant differences occurred in plasma lipid hydroperoxide
able 1
edians and their quartiles (25th–75th) of TRAP, total LOOH, and LDL
Green tea group Soy group
n Median (25–75) n Median (25–75
RAP
Baseline 25 759 (636–895) 25 791 (751–85
45 d 25 928 (804–1073)† 25 1003 (933–11
90 d 25 958 (829–1076)*† 25 932 (818–10
OOH
Baseline 25 21 900 (16 050–26 280) 25 21 932 (17 125
45 d 25 17 000 (10 850–24 500) 25 18 545 (13 727
90 d 25 18 500 (14 550–27 650) 25 18 800 (13 000
DL-LOOH
Baseline 25 9927 (8669–13 522) 25 11 371 (8357–1
45 d 25 6466 (4230–9665) 25 9958 (5567–1
90 d 25 7284 (3297–12 287) 25 11 670 (5547–1
LDL-LOOH, low-density lipoprotein lipid hydroperoxides; LOOH, lipi
* Statistically significant difference between green tea and control grou
† Statistically significant difference within green tea group, baseline ver
‡ Statistically significant difference within soy group, baseline versus 4
§ Statistically significant difference within soy/green tea group, baseline
 Statistically significant difference within control group, baseline versus 45 devels (23%, 45%, 14%, and 26% in each group, respec-
ively) or in isolated LDL hydroperoxide levels (15%,
3%, 11.7%, and 16%) at any evaluation moment for
ll groups studied.
No statistically significant differences occurred between
MI and abdominal circumference when comparing the
roups studied (data not shown).
Regarding the lipid profile, no statistically significant
ifferences were observed in the concentrations of triacyl-
lycerols (12%, 13%, 36%, and 36%), HDL cholesterol
1.1%, 5%, 5%, and 0.6%) and LDL cholesterol (6%, 6%,
%, and 1.6%) among groups. However, total cholesterol
resented a statistically significant reduction within the soy/
reen tea group (P  0.002) between the baseline evalua-
ion and after the 45-d intervention and 90 d (P  0.028)
ith 6% of change (Table 2). The percentages of change in
he other groups were 2%, 6.9%, and 3.7%.
iscussion
Diets based on polyphenols, substances renown for their
ntioxidant power, have been associated with a decrease in
ardiovascular disorders [15]. Among soy-based products,
inako (toasted ground soy beans) possess a large concen-
ration of isoflavones [16]. The consumption of approxi-
ately 50 mg of isoflavones per day is recommended for
deal hypocholesterolemic action [17]. In this study, the soy
nd soy/green tea groups ingested 31.2 mg of isoflavones
er day. In the tea ingested by the patients, the daily con-
entration of EGCG was 145 mg/500 mL (3 g of leaves in
00 mL of water). In the groups under study (soy, green tea,
oy/green tea), statistically significant increases in TRAP
ere observed. Similar results in relation to soy use were
in all groups studied
Soy/green tea group Control group
n Median (25–75) n Median (25–75)
25 738 (599–785) 25 920 (838–1066)
25 930 (834–1000)§ 25 767 (657–931)
25 937 (821–1048)§ 25 728 (658–796)*
0) 25 17 450 (13 837–24 685) 25 14 000 (9600–14 750)
5) 25 18 800 (15 470–21 700) 25 10 700 (8300–15 950)
0) 25 17 500 (13 100–23 800) 25 13 000 (7800–17 250)
) 25 14 172 (8093–17 393) 25 4471 (2967–6984)
) 25 11 594 (59 765–19 502) 25 4246 (1514–7193)
) 25 15 124 (8487–25 330) 25 5453 (3516–10 968)
operoxides; TRAP, total plasma antioxidant capacity
 0.0001).
d (P  0.007) and baseline versus 90 d (P  0.007).
 0.001).
s 45 d (P  0.006) and baseline versus 90 d (P  0.007).-LOOH
)
4)
70)‡
45)
–23 65
–23 63
–22 00
7 549
2 818
5 253
d hydr
ps (P
sus 45
5 d (P
versu(P  0.02) and baseline versus 90 d (P  0.001).
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566 M. Bertipaglia de Santana et al. / Nutrition 24 (2008) 562–568ound by other investigators in a study involving women
ho ingested 40 g of soy-based products with 110 mg of
soflavones for 4 wk [18].
In a study involving healthy volunteers who ingested
00 mL (5.0 g of leaves) and 450 mL (7.5 g of leaves) of
reen tea, a significant increase in TRAP was also ob-
ained [19]. Similarly, other researchers have observed an
xpresive improvement in TRAP when offering five cups
f green tea per day over 4 wk to their patients [20].
ccording to the investigators, the increase in plasma
ntioxidant defenses verified by TRAP was important for
he prevention of oxidation compounds present in the
lood [20].
In the control group, in which a reduction in the
ngestion of cholesterol and saturated fatty acids and an
ncrease in PUFAs was planned, a statistically significant
eduction in antioxidant defenses occurred, also verified
y TRAP. This may be due to increased ingestion of
UFAs because the individuals of this group maintained
heir BMI after 90 d, revealing that no alteration in
aloric ingestion occurred during the study.
Diets rich in monounsaturated fatty acids generate
articles of LDL that are less susceptible to oxidation
hen compared with the LDL isolated from individuals
ho ingest a PUFA-rich diet [21]. Some studies have
ndicated a large concentration of oxidation products,
uch as conjugated dienes or plasma hydroperoxides,
fter the consumption of diets involving a large quantity
f PUFAs compared with diets rich in monounsaturated
atty acids. The formation of hydroperoxides in PUFA-
ich diets is directly proportional to the quantity of dou-
le bonds contained in the fatty acids [22].
able 2
edians and their quartiles (25th–75th) of total plasma cholesterol, HDL,
Green tea group Soy group
n Median (25–75) n Median (25–
otal cholesterol
Baseline 25 240 (228.5–274.5) 25 263 (247.5
45 d 25 250 (228–269.5) 25 262 (240.5
90 d 25 264 (239–278.5) 25 259 (240–3
DL
Baseline 25 44 (35.5–54.5) 25 44 (32.75
45 d 25 43 (34–53.5) 25 44.5 (33.50
90 d 25 45 (34.5–56.5) 25 45 (38.25
DL
Baseline 25 163 (143.50–202) 25 181 (160.5
45 d 25 172 (156–181.75) 25 177 (161.2
90 d 25 180 (166–206) 25 177.5 (154–2
G
Baseline 25 132 (88–198) 25 177 (122.5
45 d 25 149 (100.5–198) 25 176 (136–2
90 d 25 144 (98–168.5) 25 174 (114–2
HDL, high-density lipoprotein; LDL, low-density lipoprotein; TG, triac
* Statistically significant difference within soy/green tea group, baselin
† Statistically significant difference within soy/green tea group, baselineIn a study involving young pregnant women, a high level pf isoprostane (a product of lipid peroxidation) excretion
as detected. These patients ingested diets rich in PUFAs,
pecifically linoleic acid. Because these acids can serve as
ubstrate for lipid peroxidation, PUFA-rich diets could con-
ribute to increased oxidative stress, which is an imbalance
etween the production of pro-oxidant and antioxidant sub-
tances in the organism [23].
Although all groups that ingested polyphenols presented
ncreased TRAP, no reduction in the formation of lipid
ydroperoxides was observed. In contrast, other investiga-
ors found significant reductions in lipid hydroperoxide lev-
ls in women who ingested soy protein for 4 wk [17].
The present study also presented no statistically signifi-
ant reduction in hydroperoxide levels in relation to isolated
DL. Given the hydrophilic characteristics of isoflavones,
hey probably present certain difficulties when incorporat-
ng into LDL particles [24]. Thus, only a slight interioriza-
ion of isoflavones occurs in these lipoproteins. This fact
ould have contributed to the absence of lower hydroper-
xide levels in the isolated LDL of the patients.
After studying the inhibition of lipid peroxidation in vivo
y polyphenol-rich beverages, such as green and black teas
nd red and white wines, researchers observed that these
ncreased plasma antioxidant potential by different degrees
n healthy individuals. The investigators concluded that the
ssociation of diverse polyphenol classes could act syner-
etically, leading to a significant increase in antioxidant
efenses in vivo [25].
In a recent meta-analysis of 17 studies, it was con-
luded that the risk of myocardial infarct diminished 11%
ith the ingestion of three cups of green tea per day [26].
he individuals who made up part of the present study
and TG in the groups studied at each stage
Soy/green tea group Control group
n Median (25–75) n Median (25–75)
) 25 257 (244–290) 25 257 (244.5–276)
) 25 245 (224.5–261)* 25 250 (234–264)
25 246 (237.5–269)† 25 255 (232–279.7)
25 45.5 (37.75–53.50) 25 44 (38.5–53.5)
) 25 44 (39.25–58.0) 25 46 (38–54.5)
) 25 49.5 (44.5–56.0) 25 45 (35.7–51.0)
25 187 (167–196) 25 178 (148.5–196.5)
5) 25 170.5 (156.75–192.25) 25 173 (153.5–189.5)
) 25 183 (162.25–193.25) 25 184.5 (146.5–203.7)
25 170 (109.5–295.5) 25 147 (122.5–226.5)
25 141 (92.5–247.5) 25 159 (118–201)
25 128 (78–241.5) 25 127 (92.75–203.25)
erol
s 45 d (P  0.002).
s 90 d (P  0.028).LDL,
75)
–292.5
–309.5
06.5)
–53.0)
–59.25
–58.75
–215)
–199.7
05.75
–242)
15)
42.5)
ylglyc
e versuresented moderate hypercholesterolemia, with the me-
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567M. Bertipaglia de Santana et al. / Nutrition 24 (2008) 562–568ian varying from 240 to 263 mg/dL. A significant re-
uction in total plasma cholesterol occurred only in the
oy/green tea group after 45 and 90 d of intervention
ompared with the baseline value. However, when com-
aring among total cholesterol, LDL, HDL, and triacyl-
lycerols in all groups, no statistically significant differ-
nces were observed.
Some researchers have stated that soy-based diets pos-
ess no significant hypocholesterolemic action in normo-
holesterolemic individuals. Moreover, they have reported
hat the hypocholesterolemic effect is directly proportional
o cholesterol concentration before intervention [27–29]. In
study assessing three soy protein bars per day to normo-
ipidemic individuals for 2 wk, no alterations in total cho-
esterol, LDL, HDL, and triacylglycerols were observed at
he end of the protocol [30].
In this study, no significant difference occurred in the
reen tea group in relation to the lipid profile. In a large
opulational study, after adjustment by multivariable lin-
ar models, some investigators concluded that healthy
apanese workers showed a 2% reduction in plasma cho-
esterol after ingesting 10 cups of green tea per day.
owever, no alterations occurred in HDL cholesterol and
riacylglycerol levels [6]. According to the investigators,
espite the minimal decrease, a 1% reduction in total
holesterol means a 2–3% diminished risk of cardiovas-
ular disease in Western countries and 5% for the Chinese.
n contrast, other investigators have found no association
etween green tea consumption and improvement in lipid
rofile [6]. Corroborating these results, in 13 epidemiologic
tudies involving green tea ingestion to verify its hypocho-
esterolemic action, only four showed a significant reduc-
ion in lipids [31].
In this work, improvement in the lipid profile of patients
as not observed in those who ingested soy or green tea
lone but only in the soy/green tea group.
Considering the present data, it is possible that no sig-
ificant improvement in plasma lipid levels was observed in
he soy and green tea groups due to the moderate dyslipi-
emia of these patients. The association was shown to be
ore effective in this respect.
The results of this research demonstrate that soy flour
nd green tea, alone or in association, increased TRAP.
hen combined, these substances presented a synergy in
elation to the hypocholesterolemic property.
In conclusion, the present study could not prove that
he products used by the patients help avoid cardiovas-
ular disorders; however, it contributed by providing a
learer understanding of how they might assist toward
his end. If soy and green tea in isolation were shown to
e important for increasing TRAP, the same was not
erified in relation to the lipid profile, where the com-
ined ingestion of soy and green tea appeared to provide
ore satisfactory results.eferences
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